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Abstract The heterotrimeric G-protein a-chain G~q plays a crit- 
ical role mediating receptor-linked activation of the/3 isoforms 
of PLC which hydrolyse membrane inositol-containing phospho- 
lipids to generate the second messengers inositol 1,4,5-tris- 
phosphate and diacylglycerol. Despite knowledge of the three- 
dimensional structure of two G-protein a-chains (G~ and G~I) 
as well as high regional amino acid conservation between mem- 
bers of the G-protein a-chain family, the precise molecular do- 
mains of G~q mediating activation of PLC~I are unknown. To 
map sites responsible for effector interaction we employed 188 
peptides each of 15 residues and corresponding to overlapping 
regions of the complete G~q sequence. These were tested for their 
ability to inhibit G~q-dependent activation of recombinant 
PLC/M using an in vitro reconstitution assay. Peptides from two 
regions of G~ mediated up to 100% inhibition of GTPyS-stimu- 
lated PLC~I activity, and representative peptides from each of 
these regions were half-maximally effective at 69.3 + 27.4/tM 
(n = 4) (G~q: 251-265) and 110.0 + 41.9 pM (n = 4) (G~q: 306- 
319). G~q regions described by inhibitory peptides are conserved 
selectively in other G-protein a-chains linked to PLC~I activa- 
tion (G~n, Gal4) and correspond spatially to sites of effector 
interaction identified in G~ by scanning mutagenesis and in 
transducin using site-specific antibodies and peptides. Computer 
homology modelling of G~q based on the crystal structure of 
transducin indicates that regions interacting with PLC~I form 
two parallel a-helices lying at the surface of the G~q structure. 
These observations provide the first description of two regions 
within G~q critically important for activating PLC~I, and more- 
over, indicate that effector binding domains identified in 
transducin and G~ are also conserved spatially in G~q. 
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I. Introduction 
Receptors of the seven transmembrane superfamily play a 
critical role detecting diverse extracellular signals [1,2]. They 
control a multitude of cell functions through activating hetero- 
trimeric G-proteins which in turn trigger regulation of a se- 
lected repertoire of downstream effector and second messenger 
systems [1,2]. Recent determination of the three-dimmensional 
structure of two G-protein a-chains (G~t and Gait) reveals con- 
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siderable molecular detail of activation-dependent conforma- 
tional changes as well as core residues likely to play crucial roles 
in GTP binding and hydrolysis [3-6]. These crystal structures 
also identify domains forming contiguous sequences at the mo- 
lecular surface and therefore of potential importance for regu- 
latory interactions with receptor, G-protein fl?' dimers and 
effector targets. To identify unequivocally sites critical for G- 
protein a-subunit interaction with other regulatory compo- 
nents it is necessary to combine analysis of G-protein structure 
with studies designed to probe the functional importance of 
specific molecular domains. This has been illustrated by inves- 
tigations with pertussis toxin [7], site-directed antibodies [8 11], 
synthetic peptides [12,13], as well as analysis of mutations [14~ 
17] which have identified the carboxyl-terminal of many a- 
chains as an important site for receptor interaction. Together 
with analysis of three-dimmensional structure, this information 
provides invaluable insight into both protein membrane orien- 
tation and molecular contacts at the receptor/G-protein inter- 
face. 
An additional protein protein interaction of fundamental 
importance within G-protein linked signal transduction path- 
ways is that between a-chains and downstream effector targets. 
One second messenger system of critical importance for cell 
regulation is increased breakdown of inositol-containing 
phospholipids by phospholipase C (PLC). This generates the 
second messengers inositol 1,4,5-trisphosphate nd diacylglyc- 
erol which mobilize Ca 2+ stores and activate protein kinase C, 
respectively [18,19]. Molecular dissection of the major compo- 
nents underlying this pathway implicate G-protein a-chains of 
the Gq class and moreover, have identified fl isoforms of PLC 
as specific effector targets for regulatory activation [2,20-25]. 
Despite the clear recognition of Gq a-chains as important reg- 
ulators of phosphoinositide hydrolysis, we remain ignorant of 
the precise structural domains and sites of interaction underly- 
ing activation of PLCfl. For other G-protein systems muta- 
tional analysis and peptides have been used to probe regions 
within G~s and Gat important in mediating activation of their 
respective ffector targets, adenylyl cyclase and cyclicGMP 
phosphodiesterase [26-29]. However, no such studies have re- 
ported the identity of key residues within the Gq class of a- 
chains in their interaction with PLCfl. We report here the use 
of synthetic peptides corresponding to overlapping regions of 
the entire sequence of G~q which were tested for their ability 
to block activation of recombinant PLCfll by GTPyS-ligated 
G~q. This approach identifed clusters of peptides from two 
distinct regions of G=q which mediated inhibition of G~q-linked 
PLCfll activation. Although separated in linear sequence, com- 
puter modelling reveals that these peptides describe two 
cz-helical domains lying parallel to one another at the surface 
of G~q. 
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2. Exper imental  
2.1. Peptide synthesis and purification 
Peptides of 15 amino acids corresponding to overlapping regions 
(with steps of one or two residues) from the entire mouse G~q sequence 
[30] were custom synthesized byChiron Mimotopes (Clayton, Victoria, 
Australia) using multiple pin synthesis technology. All peptides were 
acetylated and amidated at the amino- and carboxy-termini, respec- 
tively. In total, 188 individual peptides were tested for inhibition of 
GTPTS-stimulated PLCfll activation (see below) at a final concentra- 
tion of ~500 pM. For further analysis of inhibitory activity, selected 
peptides (as indicated) were resynthesized by Neosystem Laboratoire 
(Strasbourg, France). These were purified to >95% by reverse phase 
high pressure liquid chromatography using a Nucleosil 300-7 C8 col- 
umn (Machery-Nagel ET 2501814); buffer A, 0.1% (w/v) TFA/water; 
buffer B, 0.09% TFA/80% acetonitrile/water; flow rate, 1.0 ml/min and 
a 0-75% gradient of buffer B over 60 rain. 
2.2. Strains, media and plasmM constructs 
The host strain for S. pombe transformation with PLCfll, h +, leul 32, 
ura4-dlS, ade6 704, his5-303 was based on the original wild type 975h + 
strain from the Berne collection and constructed using standard genetic 
procedures [31]. Growth media and the procedure for protoplast trans- 
formation are as described [32]. The bacterial strain for routine work 
was JM101TR (supE, thiL srl::tnlO, recA A(lac-proAB), [F', traD36, 
proAB, lacIZAMI5]) and standard media were used throughout• The 
G~q and PLCfll cDNAs were provided by Professor M.I. Simon (Cal- 
ifornia Institute of Technology, Pasadena) nd Dr. P. Parker (Imperial 
Cancer Research Fund, London), respectively, and were as reported 
[30,33]. For expression in fission yeast, coding sequences from the 
PLCfll cDNA was excised using appropriate r striction enzymes and 
subcloned into the nmtl-based expression vector pREP3 [34]. G2q ex- 
pression in baculovirus-infected Spodopterafrugiperda (Sfg) cells was 
performed as described [35]. 
2.3. Preparation of yeast homogenates 
Suitably transformed S. pombe cells were grown overnight to station- 
ary phase in minimal medium containing 4 pM thiamine after which 
they were diluted to 5 x 105 cells/ml in fresh minimal medium and 
cultured with or without exogenously added thiamine for another 18 
h until late log-phase (1-2 x 107/ml). For homogenization yeast cells 
were washed in 0.9% (w/v) NaC1 and broken by vigorous vortexing for 
4 x 1 min at 4°C in the presence of 1.5 ml of glass beads (500 ~m 
diameter) and 100 pl of buffer P (10 mM Tris-HCl, 1 mM EGTA, 0.5 
mM phenylmethylsulfonyl fluoride (PMSF), 10 pg/ml leupeptin, 10 
pg/ml chymostatin, 10 ,ug/ml aprotonin, pH 7.4). A further 400 pl of 
buffer P was then added and the homogenate r covered by low speed 
centrifugation after piercing the base of the tube. The homogenate was 
further centrifuged at 1000 × g for 5 min to pellet unbroken cells and 
debris. The supernatent containing both particulate material and solu- 
ble proteins was designated crude homogenate. Using this protocol 
1 x 109 cells yields routinely crude homogenates with a protein content 
of 10 15 mg/ml. 
2.4. Measuring PL C~l activity with exogenous substrate 
For Gq preactivation, crude homogenates of G~q-expressing bacu- 
lovirus infected Sf9 cells or transformed S. pombe were diluted 5- to 
10-fold in buffer C (5 mM Tris-HCl, 10 mM MgC12, 1 mM dithiothre- 
itol (DTT), pH 7.2) containing GTPTS or GDPflS and incubated at 
37°C for 60 rain. This was used a source of Gq for subsequent incuba- 
tion with PLCfll (see below). To prepare xogenous substrate to meas- 
ure PLCfl I activity, approximately 1 ,uCi of [inositol-2-3H]phosphatidy - 
linositol 4,5-bisphosphate ([3H]PIP2; 8.0 Ci/mmol) (New England Nu- 
clear; Regensdorf, Switzerland) was mixed with 110 pl each of 
phosphatidylethanolamine and phosphatidylserine from bovine brain 
(10 mg/ml; Sigma Chemie, Buchs, Switzerland) in glass tubes and dried 
under vacuum with centrifugation. Following addition of 45/11 of 5 mM 
PIP, from bovine brain (Fluka Chemie AG, Buchs, Switzerland) dis- 
solved in 50 mM HEPES, 100 mM KC1 and 10 mM deoxycholate (pH 
7.0), phospholipids were resuspended in 1.0 ml of 20 mM HEPES, pH 
7.2, containing 100 mM NaCI using a bath sonicator for 5 min followed 
by 4 x 10 s with a probe sonicator at full power. Aliquots of substrate 
(25 pl) were added to glass tubes together with 25 pl of buffer B (50 mM 
Tris-HCl, 50 mM maleic acid, 40 mM LiCI and 20 mM MgCI2 at 
pH 7.0) containing CaCl2 at concentrations calculated to give defined 
free Ca 2÷ levels between 10 8 M and 10 -3 M (based on 1 mM ethylene 
glycol-bis (fl-aminoethyl ether)-N,N,N',N'-tetra acetic acid (EGTA)). 
To initiate reactions, 25 pl of preactivated G~q in Sf9 cell homogenates 
followed by 25 pl of PLCfll extract (from S. pombe transformed with 
PLCfll and diluted 15-fold in 5 mM Tris-HCl, 4 mM EGTA, 1 mM 
DTT, pH 7.2) were added, vortex mixed, and incubated at 35°C for 30 
min in a shaking water bath. When G=q peptides were tested these were 
added as 5 pl aliquots dissolved in DMSO. Reactions were stopped by 
adding 1.2 ml of an ice-cold mixture of methanol:chloroform:HCl 
(200:100:1 (v/v)) followed by a further 0.5 ml of chloroform, 0.5 ml 
of 0.25 M HC1 and vortex mixing. Samples were then centrifuged at 
1000×g for 5 min and 0.5 ml of upper aqueous phase counted for 
radioactivity by scintillation spectrometry. 
2.5. Molecular modelling of G~q 
The murine G2q sequence was from SwissProt (entry GBQ_MOUSE; 
Accession umber: P21279) while the bovine G~t structural co-ordi- 
nates were obtained through the Brookhaven Protein Data bank (entry 
ITND). The sequences of mouse G~q and G~ were aligned with SIM 
[36]. The modelling procedure for G=q involved steps implemented in 
the automated protein modelling package ProMod [37]: (i) the genera- 
tion of a framework for all atoms; (ii) the rebuilding of two loops with 
a one residue deletion; (iii) rebuilding of missing backbone atoms; and 
(iv) the addition of missing side chains and their optimisation. Subse- 
quent optimisation of bond geometry and relief of unfavourable non- 
bonded contacts was performed by 30 steps of steepest descent followed 
by 500 steps of conjugate gradient minimisation using the CHARMM 
package [38] with the PARAM 19 parameter set. After visual inspection 
some surface side chains were moved to more suitable rotamers and the 
dimer structure was further optimised by 2000 steps of conjugate gradi- 
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Fig. 1. Recombinant PLCfll produced in fission yeast is activated by 
Ca -,+ and by G~q produced in baculovirus-infected Sf9 insect cells. 
S. pombe transformed with pREP3/PLCfll was grown for 18 h in the 
absence of thiamine after which time homogenates were prepared by 
cell breakage with glass beads. (A) Hydrolysis of exogenous [3H]PIP2 
to generate [3H]IP3 by yeast extracts expressing PLCfll in the presence 
of increasing concentrations of free Ca 2+. Control cells gave no detect- 
able [3H]PIP2 hydrolysis under identical conditions. (B) PLCfll stimu- 
lated by G~q produced by baculovirus-infected Sf9 cells preactivated by
incubation i the presence of increasing concentrations of GTPTS. Free 
Ca 2+ levels were maintained at 10 7 M. GDPflS pretreated Sf9 extracts 
are unable to stimulate PLCfll activation. Data points are the mean of 
triplicate determinations and are representative of at least 3 independ- 
ent experiments• 
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ent minimisation. The 3D-1D profile matching procedure of Liithy et 
al. [39] was used to assess the quality of the models. 
3. Results and discussion 
Bovine PLCfll subcloned into pREP1 for expression in fis- 
sion yeast (see section 2) was immunodetectable as a 150 kDa 
protein localized predominantly in membrane fractions (not 
shown). Yeast extracts hydrolysed exogenously supplied 
[3H]PIP2 and this activity was stimulated markedly by increas- 
ing levels of free Ca ~+ in the concentration range l0 -7 to 10-SM 
(Fig. 1A). 100% of the [3H]PIP~ hydrolytic product co-eluted 
with authentic [-~H]IP3 following separation using anion-ex- 
change resin mini-columns (data not shown). No PLC activity 
was detectable under identical conditions using control cells 
expressing pREP vector alone (data not shown). As reported 
recently [40], Gctq expressed in baculovirus-infected Sf9 insect 
cells stimulates PLCfll activation following preactivation by 
incubation in the presence of increasing concentrations of 
GTP),S (Fig. 1B). GDPflS was ineffective under identical condi- 
tions. 
To map molecular domains within G~q responsible for inter- 
action with PLCfll we measured GTPyS-stimulated PLCfll 
activation in the presence of synthetic peptides corresponding 
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Fig. 2. Inhibition of G~q-stimulated PLCfll activity by synthetic pep- 
tides corresponding to 15 amino acid sequences within G~q. PLCfll was 
activated by Sf9 cell extracts expressing G~q preincubated in the pres- 
ence of 10 -4 M GTPyS and [3H]PIP zhydrolysis measured in the pres- 
ence of overlapping synthetic peptides from G~q as indicated. A total 
of 188 peptides were tested independently ata final concentration of 
500 pM. Two clusters of inhibitory activity were detected for peptides 
corresponding to amino acids 249-269 (A) and 302 321 (B) of the G=q 
primary amino acid sequence. Lower and upper horizontal lines indi- 
cate unstimulated and G~q-dependent PLCfll activity measured in the 
absence of peptide. Bars represent the mean of duplicate determinations 
for peptides inhibiting PLCfll activation i at least wo separate exper- 
iments. 
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Fig. 3. Dose-dependent i hibition of G~q-dependent PLCfll activity by 
purified synthetic peptides: G=q: 251-265 (SKALFRTIITYPWFQ) and 
G~q: 306-319 (AREFILKMFVDLNPD). [3H]PIP2 hydrolysis by G=q- 
activated PLCfl 1 was measured in the presence of increasing concentra- 
tions of HPLC-purified synthetic G~q peptides as indicated. G=q: 251- 
265 and G~q:306-319 mediated complete inhibiton of GTPTS-activated 
PLCfll while G~q: 300-313 and G~q: 318 335 were ineffective at concen- 
trations up to 500 pM. Horizontal line indicates basal PLCfll activity 
measured inthe absence of GTPyS-stimulated Gc~q. Points are the mean 
of duplicate determinations and representative of 4 separate determina- 
tions. Identical results were obatined using two separate batches of 
peptide and independent HPLC purifications. 
to overlapping sequences for the entire Goq molecule [30]. We 
tested 188 peptides, each of 15 amino acids at a final concentra- 
tion of 500 pM. We observed two major clusters of peptides 
inhibiting G~q-dependent PLCfll activation by up to 100%. 
Peptides clearly inhibitory on G~q function correspond to resi- 
dues 249-269 and 302-321 of the G=q sequence (Fig. 2A,B). To 
confirm these inhibitory properties two representative p ptides, 
G~q: 251-265 (SKALFRTIITYPWFQ) and Gaq: 306-319 
(AREFILKMFVDLNPD),  were resynthesized and purified 
using HPLC. Both G=q: 251-265 and G~q: 306-319 inhibited 
Goq-stimulated PLCfll activity in a dose-dependent fashion dis- 
playing ICs0 values of 69.3 + 27.4/,tM (n -- 4) and 110.0 + 41.9 
/,tM (n -- 4), respectively (Fig. 3). These concentrations are sim- 
ilar to those required for peptides from the carboxyl-terminal 
of G~s and Got for blockade of G-protein interaction with recep- 
tor [12,13,41]. Two purified control peptides corresponding to
regions G~q: 300-313 (RDAQAAREFILKKMF)  and G~q: 
318-335 (PDSDKIIYSSHFTCATDTE) which overlap with 
the amino- and carboxyl-termini of Goq: 306-319 were both 
ineffective at blocking G~q action at any concentration up to 
500 pM (Fig. 3). 
It may be expected that the inhibitory peptides Gaq: 251-265 
and G~q: 306 319 exhibit the ability to fold into a three-dim- 
mensional comformation mimicking cognate regions on the 
surface of the G~q thereby competing for interaction with recog- 
nition sites on PLCfll. In order to assess the molecular localiz- 
ation of these inhibitory peptides, we set out to model the G~q 
structure based on the crystal structural coordinates of 
GTP)'S-G~t [3] (see section 2). When assessed for accuracy 
using the Profile method of Liithy et al. [39], our Goq computer 
model (Fig. 4) displayed a 3D-1D mean score of 0.53. This is 
close to the score established for the Got structure (0.56) indicat- 
ing that no major folding errors were detectable. This is as 
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Fig. 4. Computer homology model of G=q structure based on GTPyS-bound G=~. The G~t qmodel is depicted by a grey ribbon (Carson, M. (1990) 
J. Appl. Cryst. 24, 958-961) while the bound GTPyS is shown in magenta. The three regions which conformation changes upon GTP binding are 
shown in blue and are called switch I to III (Lambright, D.G., Noel, J.P., Hamm, H.E. and Sigler, P.B. (1994) Nature 369, 621~528). The two synthetic 
peptides with the maximal inhibitory activity G~q-stimulated PLCfll are shown in red (ct3 helix: residues 252 to 266) and yellow (ct4 helix: residues 
306 and 319). Both helices are located in the ras-homology domain. 
expected as Gaq is 52% identical to Gat and should therefore 
share a high degree of structural resemblance. This is illustrated 
by another G-protein a-chain, G~,, which displays a three- 
dimensional conformation very similar to that of the G~t crystal 
structure including the position of surface a-helices and loop 
structures [3-6]. Using our model we have mapped the position 
of the two inhibitory peptides and Fig. 4 shows their relative 
position within the G~q structure. Interestingly, both peptides 
are located within the ras-like domain with G~q: 251-265 and 
G~q: 306-319 corresponding to helices a3 and ct4, respectively 
(nomenclature according to [3]). These two helices are adjacent 
to one another, and moreover, are localized at the molecular 
surface of G=q thereby providing abroad surface for interaction 
with PLCfll. 
The combination of functional data with inhibitory peptides 
together with homology modelling of G~ suggests an impor- 
tant role for helices a3 and a4 in mediating effector interaction. 
Such a conclusion is consistent with functional studies per- 
formed with G~t where peptides corresponding to these regions 
mediate activation of cyclic GMP phosphodiesterase through 
binding inhibitory regulatory -subunits [26,27]. Additional 
studies mapping sites of effector interaction have also been 
performed for Gas where scanning mutagenesis has identified 
4 domains important for activation of adenylyl cyclase [29]. 
Based on sequence alignments two of these also map to the a3 
and a4 effector binding helices identified within G~t [26,27] and 
G~q (this study). It is of note that despite high spatial conserva- 
tion of helices a3 and a4 within the three-dimmensional struc- 
tures of Got, G~s and apparently also Gaq, the primary se- 
quences in these regions are highly divergent and this may 
contribute to G-protein specificity of interaction with different 
effector and second messenger systems. Consistent with this, 
G-protein a-chains coupling to common effector and second 
messenger systems show high conservation of primary se- 
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Table 1 
Alignment of primary amino sequences from a subset of G-protein ~-chains within the regions corresponding to inhibitory peptides G~q: 251 265 
and G=q: 306-319 
Subunit Gaq inhibitory peptides and aligned sequences Effector Coupling 
G=q: 251-265 G~q:306-319 
(~x3--a3/f15) ~4-c~4/fl6) 
G=q SKALFRT I I TYPWFQ AREF  I LKMFVDLNPD I" PLCfl 
G~H SKALFRTI ITYPWFQ AREF I LKMFVDLNPD "1" PLCfl 
G~4 SKALFRT I  ITYPWFL ARDFILKLYQDQNPD I" PLC;9 
G=s ALNLFKS IWNNRWLR AKYF  I RDEFLRI  S TA I" AC  
G=o~r SLDLFES IWNNRWLR AKFF IRDLFLR ISTA "['AC 
G,, SLHLFNS ICNHRYFA . GNYI  KVQFLELNMR I" cGMP-PDE 
G~o SLKLFDSICNNKFF I  . AAYIQAQF.  ESKNR $ AC/VDCC 
G=i~ SMKLFDS ICNNKWFT . AAY IQCQFEDLNKR ,~AC 
G~i 2 SMKLFDS ICNNKWFT . ASY IQSKFEDLNKR ,[,AC 
G=~ SMKLFDS ICNNKWFT . AAYI  QCQF]EDLNRR ,[,AC 
G=z SLRLFDSICNNNWFI  . AVY IQRQFEDLNRN SAC 
Subunits are grouped according to known regulation of major downstream effector targets. Nomenclature of structural helices (shown in parenthesis) 
corresponding to peptide sequences are according to [3]. Effector targets are: fl isoforms of phospholipase C (PLCfl), adenylyl cyclase (AC), retinal 
cyclic GMP-phosphodiesterase (cGMP-PDE) and voltage-dependent Ca z+ channels (VDCC). G-protein coupling was demonstrated by either 
recombinant expression of selected components or use of antibodies, peptides or antisense oligonucleotides to block endogenous G-protein function 
(see text for details). 
quence within the two regions defined by the inhibitory pep- 
tides Gc~q: 251-265 and G~q: 306-319 (Table 1). These include 
activation of PLCfll by G=q, G~ and G~14 [22-24,40,42,43], 
stimulation of cyclicGMP-phosphodiesterase by Got [44], and 
regulation of adenylyl cyclase by Gas [45,46], G~ojf [47], G~a~ 
[48,49] and G= [48]. G~i and G~o also play a role regulating Ca 2+ 
channel activity [50-52]. As anticipated from such a subclassifi- 
cation, functionally distinct G-proteins display considerably 
less homology within both regions. 
In summary, we report the use of a series of synthetic pep- 
tides based on overlapping regions from the entire sequence of 
G~q to localize sites critical for G~q-dependent activation of its 
downstream effector PLCfll. We observed two clusters of 
blocking peptides mapping to two distinct domains and repre- 
sented by G~q: 251 265 and G=q: 306-319. Computer modelling 
of G~q reveals that inhibitory peptide sequences form two par- 
allel s-helices lying at the surface of Gc~ q. These observations 
provide the first description of two regions within G~q critically 
important for activating PLCfll, and moreover, indicate that 
effector binding domains identified in transducin and Gas are 
conserved spatially in G~q. 
Acknowledgements: We are grateful to Professor M.I. Simon (Califor- 
nia Institute of Technology, Pasadena) and Dr. E Parker (Imperial 
Cancer Research Fund, London) for cDNAs encoding, respectively, 
mouse G~q and bovine PLCfll. We are also grateful to Charles Brad- 
shaw for HPLC purification of peptides and Dr. J. Knowles for unfail- 
ing support and encouragement. 
References 
[1] Dohlman, H.G., Thorner, J., Caron, M.G. and Lefkowitz, R.J. 
(1991) Annu. Rev. Biochem. 60, 651~588. 
[2] Watson, S. and Arkinstall, S.J. (1994) The G-Protein Linked Re- 
ceptor Factsbook, Academic Press, London. 
[3] Noel, J.P., Hamm, H.E. and Sigler, P.B. (1993) Nature 366, 654- 
663. 
[4] Lambright, D.G., Noel, J.P., Hamm, H.E. and Sigler, RB. (1994) 
Nature 369, 621-628. 
[5] Sondek, J., Lambright, D.G., Noel, J.E, Hamm, H.E. and Sigler, 
P.B. (1994) Nature 372, 276-279. 
[6] Coleman, D.E., et al. (1994) Science 265, 1404-1412. 
[7] West, R.E., Moss, J., Vaughan, M., Liu, T. and Liu, T.Y. (1985) 
J. Biol. Chem. 260, 14428-14430. 
[8] McKenzie, ER. and Milligan, G. (1990) Biochem. J. 267, 391- 
398. 
[9] Gutowski, S., Smrcka, A., Nowak, L., Wu, D., Simon, M. and 
Sternweis, P.C. (1991) J. Biol. Chem. 266, 20519-20524. 
[10] Shenker, A., Goldsmith, E, Unson, C.G. and Spiegel, A.M. (1991) 
J. Biol. Chem. 266, 9309-9313. 
[11] Simonds, W.F., Goldsmith, EK., Codina, J., Unson, C.G. and 
Spiegel, A.M. (1989) Proc. Natl. Acad, Sci. USA 86, 7809- 
7813. 
[12] Hamm, H.E., Deretic, D., Arendt, A., Hargrave, P.A., Koenig, B. 
and Hofmann, K.E (1988) Science 241,832-835. 
[13] Rasenick, M.M., Watanabe, M., Lazarevic, M.B., Hatta, S. and 
Hamm, H.E. (1994) J. Biol. Chem. 269, 21519-21525. 
[14] Sullivan, K.A., Miller, R.T., Masters, S.B., Beiderman, B., Heide- 
man, W. and Bourne, HR. (1987) Nature 330, 758-760. 
[15] Rail, T. and Harris, B.A. (1987) FEBS Lett. 224, 365-371. 
[16] Masters, S.B., Sullivan, K.A., Miller, R.T., Beiderman, B., Lopez, 
N.G., Ramachandran, J. and Bourne, H.R. (1988) Science 241, 
448451. 
[17] Conklin, B.R., Farfel, Z., Lustig, K.D., Julius, D. and Bourne, 
H.R. (1993) Nature 363, 274-276. 
[18] Berridge, M.J. (1987) Annu. Rev. Biochem. 56, 159-193. 
[19] Nishizuka, Y. (1992) Science 258, 607 614. 
[20] Simon, M.I., Strathmann, M.P. and Gautam, N. (1991) Science 
252, 802 808. 
[21] Kaziro, Y., Itoh, H., Kozasa, T., Nakafuka, M. and Satoh T. 
(1991) Annu. Rev. Biochem. 60, 349~,00. 
[22] Smrcka, A.V., Helper, J.R., Brown, K.O. and Sternweis, P.C. 
(1991) Science 251,804-807. 
[23] Taylor, S.J., Chae, H.Z., Rhee, S.G. and Exton, J.H. (1991) Na- 
ture 350, 516-518. 
[24] Wu, D., Lee, C.H., Rhee, S.G. and Simon, M.I. (1992) J. Biol. 
Chem. 267, 1811-1817. 
[25] Conklin et al., Farfel, Z., Lustig, K.D., Julius, D. and Bourne, 
H.R. (1993) Nature 363, 274-276. 
[26] Rarick, H.M., Artemyev, N.O. and Hamm, H.E. (1992) Science 
256, 1031 1033. 
[27] Cunnick, J., Twamley, C., Udovichenko, I., Gonzalez, K. and 
Takemoto, D.J. (1994) Biochem. J. 297, 87-91. 
[28] Itoh, H. and Gilman, A.G. (1991) J. Biol. Chem. 266, 16226- 
16231. 
[29] Berlot, C.H. and Bourne, H.R. (1992) Cell 68, 911-922. 
[30] Strathmann, M. and Simon, M.I. (1990) Proc. Natl. Acad. Sci. 
USA 87, 9113 9117. 
50 S. Arkinstall et al./FEBS Letters 364 (1995) 45-50 
[31] Gutz, H., Heslot, H., Leupold, U. and Loprieno, N. (1974) in: 
Sehizosaecharomyees pombe: Handbook of Genetics, vol. 1, (King, 
R.D. ed.) pp. 395~46, Plenum Press, NY. 
[32] Moreno, et al., 1991/Moreno, S., Klar, A. and Nurse, P. (1991) 
Methods Enzymol. 194, 795-823. 
[33] Katan, M., Kriz, R.W., Totty, N., Philip, R., Meldrum, E., Al- 
dape, R.A., Knopf, J.L. and Parker, P.J. (1988) Cell 54, 171--177. 
[34] Maundrell, K. (1993) Gene 123, 127-130. 
[35] Mills et al., 1993/Mills, A., Allet, B., Bernard, A., Chabert, C., 
Brandt, E., Cavegn, C., Chollet, A. and Kawashima, E. (1993) 
FEBS Lett. 320, 130-134. 
[36] Huang X. and Miller M. (1991) Adv. Appl. Math. 12, 337 357. 
[37] Peitsch M.C. and Jongeneel C.V. (1993) Int. Immunol. 5, 233- 
238. 
[38] Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swami- 
nathan S. and Karplus M. (1983) J. Comp. Chem. 4, 187-217. 
[39] Liithy R., Bowie J.U., and Eisenberg D. (1992) Nature 356, 83- 
85. 
[40] Helper, J.R., Kozasa, T., Smrcka, A.V., Simon, M.I., Rhee, S.G., 
Sternweis, P.C. and Gilman, A.G. (1993) J. Biol. Chem. 268, 
14367-14375. 
[41] Palm, D., Munch, G., Malek, D., Dees, C. and Hekman, M. (1990) 
FEBS Lett. 261,294-298. 
[42] Lee, C.H., Park, D., Wu, D., Rhee, S.G. and Simon, M.I. (1992) 
J. Biol. Chem. 267, 16044-16047. 
[43] Wu, D., Katz, A., Lee, C.-H. and Simon, M.I. (1992) J. Biol. 
Chem. 267, 25798-25802. 
[44] Stryer, L. (1991) J. Biol. Chem. 266, 10711 10714. 
[45] Northup, J.K., Sternweis, EC., Smigel, M.D., Schleifer, L.S., 
Ross, E.M. and Gilman, A.G. (1980) Proc. Natl. Acad. Sci. USA 
77, 6516-6520. 
[46] Codina, J., Hildebrandt, J.D., Sekura, R.D., Birnbaumer, M., 
Bryan, J., Manclark, C.R., Iyengar, R. and Birnbaumer, L. (1984) 
J. Biol. Chem. 259, 5871-5886. 
[47] Jones, D.T., Masters, S.B., Bourne, H.R. and Reed, R.R. (1990) 
J. Biol. Chem. 265, 2671 2676. 
[48] Wong, Y.H., Conklin, B.R. and Bourne, B.R. (1992) Science 255, 
339- 342. 
[49] Taussig, R., Tang, W.J., Helper, J.R. and Gilman, A.G. (1994) 
J. Biol. Chem. 269, 6093 6100. 
[50] Ewald, D.A., Pang, I.H., Sternweis, P.C. and Miller, R.J. (1989) 
Neuron 2, 1185-1193. 
[51] Kleuss, C. Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G. and 
Wittig, B. (1991) Nature 353, 4348. 
[52] Gollasch, M., Kleuss, C., Hescheler, J., Wittig, B. and Schultz, G. 
(1993) Proc. Natl. Acad. Sci. USA 90, 6265 6269. 
